Guggenheim Capital’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-227,415
| Closed | -$41.8M | – | 2275 |
|
|
2021
Q2 | $41.8M | Sell |
227,415
-7,184
| -3% | -$1.23M | 0.25% | 66 |
|
|
2021
Q1 | $35.9M | Sell |
234,599
-40,305
| -15% | -$6.23M | 0.24% | 69 |
|
|
2020
Q4 | $43M | Sell |
274,904
-40,409
| -13% | -$5.19M | 0.27% | 59 |
|
|
2020
Q3 | $36.1M | Sell |
315,313
-28,570
| -8% | -$3.08M | 0.26% | 66 |
|
|
2020
Q2 | $38.6M | Buy |
343,883
+41,048
| +14% | +$4.36M | 0.3% | 57 |
|
|
2020
Q1 | $27.2M | Sell |
302,835
-10,663
| -3% | -$1.05M | 0.28% | 69 |
|
|
2019
Q4 | $33.9M | Buy |
313,498
+3,378
| +1% | +$361K | 0.26% | 68 |
|
|
2019
Q3 | $30.4M | Buy |
310,120
+11,445
| +4% | +$1.29M | 0.24% | 76 |
|
|
2019
Q2 | $39.1M | Buy |
298,675
+5,438
| +2% | +$701K | 0.32% | 47 |
|
|
2019
Q1 | $39.6M | Buy |
293,237
+58,483
| +25% | +$7.27M | 0.32% | 46 |
|
|
2018
Q4 | $22.9M | Sell |
234,754
-17,082
| -7% | -$2.02M | 0.21% | 85 |
|
|
2018
Q3 | $35M | Buy |
251,836
+1,592
| +0.6% | +$200K | 0.24% | 56 |
|
|
2018
Q2 | $31.1M | Sell |
250,244
-322,407
| -56% | -$37.7M | 0.22% | 68 |
|
|
2018
Q1 | $63.8M | Sell |
572,651
-41,992
| -7% | -$5.02M | 0.16% | 181 |
|
|
2017
Q4 | $73.5M | Buy |
614,643
+166,839
| +37% | +$20.3M | 0.17% | 134 |
|
|
2017
Q3 | $62.8M | Sell |
447,804
-107,539
| -19% | -$14.6M | 0.16% | 167 |
|
|
2017
Q2 | $67.6M | Buy |
555,343
+124,968
| +29% | +$14.5M | 0.18% | 127 |
|
|
2017
Q1 | $52.2M | Buy |
430,375
+28,129
| +7% | +$3.63M | 0.14% | 245 |
|
|
2016
Q4 | $49.2M | Sell |
402,246
-92,435
| -19% | -$11.3M | 0.14% | 232 |
|
|
2016
Q3 | $60.6M | Buy |
494,681
+54,377
| +12% | +$7M | 0.19% | 90 |
|
|
2016
Q2 | $51.4M | Sell |
440,304
-867
| -0.2% | -$123K | 0.16% | 152 |
|
|
2016
Q1 | $61.4M | Sell |
441,171
-25,880
| -6% | -$3.8M | 0.19% | 92 |
|
|
2015
Q4 | $89.1M | Sell |
467,051
-141,908
| -23% | -$24.8M | 0.26% | 38 |
|
|
2015
Q3 | $95.2M | Sell |
608,959
-40,684
| -6% | -$7.42M | 0.3% | 23 |
|
|
2015
Q2 | $117M | Buy |
649,643
+28,834
| +5% | +$4.98M | 0.3% | 19 |
|
|
2015
Q1 | $108M | Buy |
620,809
+95,623
| +18% | +$17.3M | 0.26% | 28 |
|
|
2014
Q4 | $97.2M | Buy |
525,186
+100,204
| +24% | +$18.6M | 0.24% | 42 |
|
|
2014
Q3 | $70.5M | Sell |
424,982
-146,215
| -26% | -$24M | 0.17% | 97 |
|
|
2014
Q2 | $89.3M | Buy |
571,197
+15,058
| +3% | +$2.38M | 0.23% | 45 |
|
|
2014
Q1 | $84.6M | Buy |
556,139
+155,185
| +39% | +$24.7M | 0.24% | 43 |
|
|
2013
Q4 | $53.4M | Sell |
400,954
-110,662
| -22% | -$13.3M | 0.16% | 117 |
|
|
2013
Q3 | $59.4M | Buy |
511,616
+133,752
| +35% | +$14.7M | 0.22% | 57 |
|
|
2013
Q2 | $34.9M | Buy |
+377,864
| New | +$36.4M | 0.15% | 119 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM